Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8734 |
High Similarity |
NPD7075 |
Discontinued |
0.8726 |
High Similarity |
NPD5402 |
Approved |
0.8662 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD5403 |
Approved |
0.8627 |
High Similarity |
NPD5401 |
Approved |
0.8481 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8366 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8344 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8261 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8225 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8114 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8059 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7963 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7953 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7935 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7908 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7898 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7885 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7843 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7836 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7836 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7831 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7816 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7784 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD411 |
Approved |
0.7711 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7684 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7684 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7633 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD920 |
Approved |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7446 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7436 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7399 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7389 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7347 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7325 |
Intermediate Similarity |
NPD943 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7302 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7285 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7263 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7243 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6535 |
Approved |
0.724 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD37 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2798 |
Approved |
0.716 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7143 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7228 |
Approved |
0.707 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7066 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7065 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7025
|
Intermediate Similarity |
NPD3027 |
Phase 3 |